Does discontinuation of warfarin treatment within 6 months after bioprosthetic AVR surgery increase the risk of cardiovascular death?
Discontinuing warfarin within 6 months of bioprosthetic AVR is associated with an increased risk of cardiovascular death.
Discontinuation of warfarin treatment within 6 months after bioprosthetic AVR surgery was associated with increased cardiovascular death.
Mérie et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: